Catalyst Insider Buying Fund Class A INSAX

Medalist Rating as of | See Catalyst Investment Hub
  • NAV / 1-Day Return 26.86  /  −4.58 %
  • Total Assets 21.2M
  • Adj. Expense Ratio
    1.530%
  • Expense Ratio 1.540%
  • Distribution Fee Level High
  • Share Class Type Front Load
  • Category Mid-Cap Growth
  • Investment Style Mid Growth
  • Min. Initial Investment 2,500
  • Status Open
  • TTM Yield 0.00
  • Turnover 76%

USD | NAV as of Jun 06, 2026 | 1-Day Return as of Jun 06, 2026, 2:37 AM GMT+0

Morningstar’s Analysis INSAX

Will INSAX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Catalyst Insider Buying A holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings INSAX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 47.5
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Teva Pharmaceutical Industries Ltd ADR

7.95 1M
Healthcare

Comfort Systems USA Inc

6.40 992,873
Industrials

Talen Energy Corp Ordinary Shares New

6.35 984,825
Utilities

Kinsale Capital Group Inc

4.50 696,986
Financial Services

Palomar Holdings Inc

4.35 675,175
Financial Services

Fluor Corp

3.76 583,125
Industrials

Medpace Holdings Inc

3.69 571,426
Healthcare

Spotify Technology SA

3.63 562,496
Communication Services

Arista Networks Inc

3.46 536,549
Technology

TransMedics Group Inc

3.43 532,341
Healthcare

Sponsor Center